The Future of Injectables is Prefilled and Plastic

Accelerating Access: The Future of Injectables is Prefilled and Plastic

On Drug Delivery, Prefilled Syringes & Injection Devices, Issue #152 October 2023

Bo Kowalczyk, CCO, and Jon Ellenthal, President, discuss the need for greater fill-finish capacity in the #pharmaceutical industry highlighted by the pandemic, and how ApiJect’s #BlowFillSeal Prefilled Injector Platform aims to meet this need.

• What are the #supplychain issues impacting glass-based sterile #fillfinish services during and after COVID-19?

• What is the outlook for the #injectable medicines and #vaccines market until 2030, and to what extent has the pandemic influenced this market?
• What are the market trends, both in terms of technology and patient needs?
• What is ApiJect, what was the impetus to start the company, and what are the key problems and challenges you’re trying to solve?
• What distinct advantages does the ApiJect Platform offer compared with injectable platforms reliant on glass, and how will both sponsor and patients benefit?
• What is ApiJect’s strategy to bring forth this new technology platform and what measures are in place to mitigate risk for sponsors in an industry filled with fast followers?

Read the Full Article

Key Benefits of the Prefilled ApiJect Injector

• Expanded Market Access
• Compact Supply Chain
• Short Lead Times
• Scalable, Efficient Manufacturing
• Prefilled Format at Single Vial Costs
• Lower Carbon Footprint

The best products are designed to work as intended for every patient in every country.

The look on Esther’s Face when she experiences the Simplicity of the Prefilled ApiJect Injector.

How does the ApiJect Platform design and develop the right device for your #drugproduct?

Need to know more? Connect with Russell (Bo) Kowalczyk , PJ Kim , or Morgan Amsler to learn how the Prefilled ApiJect Injector can solver your drug delivery challenges.